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Objective: To describe the in vivo confocal microscopy (IVCM) appearances of the tarsal conjunctiva in
trachoma compared with the appearance of healthy conjunctiva and to develop grading systems for IVCM
examination of the tarsal conjunctiva for use in future studies on trachoma and other conjunctival diseases.
Design: Prospective observational study.
Participants: In vivo confocal microscopy examination was performed on 302 clinically normal adults, 16
clinically normal children, 750 adults with trachomatous conjunctival scarring, and 25 children with active
trachoma.
Methods: Clinical evaluation was performed with 2.5 loupes, and IVCM examination of the upper tarsal
conjunctiva was carried out with a Heidelberg Retina Tomograph 3 with the Rostock Cornea Module (Heidelberg
Engineering GmbH, Dossenheim, Germany).
Main Outcome Measures: In vivo confocal microscopy images were analyzed for cellular and tissue
changes associated with trachomatous inflammation and scarring compared with healthy subjects.
Results: Trachomatous subjects with follicular and papillary inflammation had an increased inflammatory
cellular infiltrate, including dendritiform cells, discrete follicular and papillary structures, and cystic lacunae
suggestive of tissue edema. Trachomatous conjunctival scarring was seen with IVCM as organization of the
subepithelial connective tissue into bands/sheets. Grading systems for inflammatory changes and scarring were
developed, with the system for scarring showing good interobserver agreement with an intraclass coefficient of
0.88.
Conclusions: In vivo confocal microscopy provides a powerful tool for examining the ocular surface.
Numerous cellular and tissue changes were observed in subjects with trachoma, the first time IVCM has been
applied to this disease. These changes both complement and add to previous histologic analyses. In vivo
confocal microscopy promises to provide new insights into the pathogenesis of trachoma and other conjunctival
diseases.
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed
in this article. Ophthalmology 2011;118:747–754
© 2011 by the American Academy of Ophthalmology. Open access under CC BY license. “
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aTrachoma is caused by recurrent infection with Chlamydia
trachomatis. The infection is most commonly found in
children who develop a chronic follicular conjunctivitis
with papillary hypertrophy, referred to as “active tra-
choma.” Later in life, such individuals are at risk of devel-
oping conjunctival scarring, entropion, trichiasis, and even-
tually blinding corneal opacification. Trachoma is an
ancient disease that was previously endemic in Europe and
North America but is now largely found in poor rural
communities in the developing world. Trachoma remains
the most common infectious cause of blindness globally
with more than 1.3 million people blind from the disease,
8.2 million with trichiasis, and 40 million with active
disease.1,2
In vivo confocal microscopy (IVCM) is a noninvasive
means of obtaining high-resolution tissue images down to
the cellular level. The illumination and observation systems
are focused on the same focal point, giving rise to the term j
© 2011 by the American Academy of Ophthalmology 
Published by Elsevier Inc. Open access under CC BY license. confocal,” so that any light originating from outside the
ocal plane is highly suppressed. This allows a magnifica-
ion of up to 800 with an optical resolution of 1 to 2 m.
his relatively new technique has shown promise in the
tudy of ocular surface disease, including corneal dystro-
hies, changes after refractive surgery, drug toxicity, and
endritic cell changes in inflammatory disease.3–5 The tech-
ique’s application to the study of ocular infections has
hown that it is able to differentiate among bacterial, fungal,
nd protozoan agents.6 Although much of the work done so
ar has been concentrated on the cornea, several studies
ave reported interesting results on the conjunctiva, includ-
ng changes in atopic keratoconjunctivitis, filtration blebs
fter glaucoma surgery, and inflammatory changes in re-
ponse to bacterial lipopolysaccharide.3,7–11
In vivo confocal microscopy has several advantages over
lternative methods of studying cellular events in the con-
unctiva. Histopathology of biopsy specimens, the “gold
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Ophthalmology Volume 118, Number 4, April 2011standard,” allows exceptional detail to be seen, but it is an
invasive procedure in which usually only a small amount of
tissue can be investigated and sequential examination over
time is not feasible. In addition, there can be artefact
changes in the tissue introduced during processing. Impres-
sion cytology can be useful; however, cells are probably
collected from only the most superficial layers of the epi-
thelium, and no information about the structure of the tissue
is provided. In vivo confocal microscopy has not been
associated with any adverse events, can be used repeatedly
all over the ocular surface, and provides high-resolution
images.
The pathogenesis of trachoma is poorly understood. The
infection itself is believed to be limited to a small minority
of the superficial conjunctival epithelial cells. It is generally
accepted that much of the tissue damage in this disease is
the result of a pathologic immune response.12–17 A limited
serovar-specific protective immunity probably develops.
However, it remains unclear why some individuals develop
blinding sequelae and others do not (with a similar infection
exposure), and what factors are important in the progression
of scarring. In vivo confocal microscopy has the potential to
provide useful insights into this disease process at the tissue
level. Specifically, IVCM can reveal the morphology and
distribution of fibrotic tissue within the palpebral conjunc-
tiva. In addition, inflammatory cell infiltrates can be exam-
ined and related to the clinical phenotype.
This article presents descriptive findings from IVCM of
the different clinical stages of trachoma and compares these
with normal tarsal conjunctiva. We also propose a grading
system for IVCM findings in subjects with trachoma to
facilitate formal image analysis in ongoing studies. It is
anticipated that this grading system will also have rele-
vance for other immuno-fibrogenic diseases of the con-
junctiva, such as mucous membrane pemphigoid and
atopic keratoconjunctivitis.
Patients and Methods
Ethical Permission
The observations presented were made during the course of studies
approved jointly by the London School of Hygiene and Tropical
Medicine Ethics Committee, the Kilimanjaro Christian Medical
Centre Ethics Committee, and the National Ethics Committee of
the Tanzanian National Institute of Medical Research. Informed
consent was obtained before enrollment of each subject.
Clinical Assessment
These studies were conducted in trachoma endemic communities
in Siha District, Kilimanjaro Region, Northern Tanzania. Subjects
were examined in a dark room or tent with 2.5 loupes and a
bright torch. Signs of trachoma were graded using the 1981 de-
tailed World Health Organization grading system, which assesses
the upper palpebral conjunctiva for follicles, papillae, and scarring,
and grades entropion/trichiasis and corneal opacity.18 A portable
slit lamp was used if a more magnified view was needed, partic-
ularly to rule out subtle conjunctival scarring in normal controls.
High-resolution digital photographs were taken of the upper tarsal
conjunctiva. e
748The protocols for the ongoing related studies involved the
ecruitment of 800 adults with trachomatous conjunctival scarring
nd 360 adults without scarring. We attempted IVCM examina-
ions on all consenting individuals. In a previously untreated
illage that was about to receive mass drug administration with
zithromycin for trachoma control, we also performed IVCM
xaminations on children who could comfortably tolerate the
rocedure.
onfocal Microscopy Assessment
n vivo confocal microscopy was performed using the Heidelberg
etina Tomograph 3 (HRT3) in combination with the Rostock
ornea Module (RCM) (Heidelberg Engineering GmbH, Dossen-
eim, Germany). This uses a 670-nm diode laser as a light source
ith a 63 water-contact objective (Olympus Europa GmbH,
amburg, Germany) covered with a sterile single-use polymeth-
lmethacrylate (PMMA) cap (Tomocap, Heidelberg Engineering).
small amount of carbomer gel (GelTears, Chauvin Pharmaeuti-
als Ltd., Surrey, UK) was used as a coupling agent between the
CM lens and the cap. The device scans an area of 400400 m
ith a magnification of 800 and a lateral resolution of 1 m.
The related study protocols required confocal examination of
he upper tarsal conjunctiva in the left eye in adults and the right
ye in children. Topical anesthesia was applied to the conjunctival
ac (proxymetacaine 0.5%, Chauvin Pharmaceuticals Ltd., Surrey,
K), and the upper eyelid was everted. Additional coupling gel
as not needed for the examination of the conjunctiva. The posi-
ion of the HRT3/RCM unit was adjusted to bring the surface of
he device into contact with the tarsal portion of the palpebral
onjunctiva, with the assistance of a live-view side video camera.
cans were taken using the “volume” setting in which 40 coronal
mages are taken in rapid succession at 2.1-m intervals from
uperficial to deep. Scans started at the conjunctival epithelial
urface, and the final scan was at a depth of 85 m. It was
enerally found that the quality of the image became impaired
eyond 85 m with little structural detail visible. The brightness
ontrol was set on automatic. Ten volume scans were taken per
atient from random locations across the tarsal conjunctiva. The
otal examination time was approximately 5 minutes. In selected
atients, scans of the marginal portion of the palpebral conjunctiva
ere also obtained in a manner similar to those of the tarsal
onjunctiva. None of the IVCM images shown in this article have
ad any adjustments made (e.g., in contrast or brightness) after
eing exported from the HRT3/RCM unit.
esults
tudy Subjects
ll IVCM examinations were performed as part of studies per-
ormed in a trachoma endemic area in Siha District of northern
anzania. The descriptions of normal and diseased conjunctiva and
he proposed grading systems are based on experience gained from
VCM examinations of 302 clinically normal adults (18 years),
6 clinically normal children (mean age 9.4 years, range 5–15
ears), 750 adults with a wide range of trachomatous conjunctival
carring, and 25 children with active trachoma (mean 6.8 years,
ange 3–17 years).
ormal Palpebral Conjunctiva
n the tarsal portion of the healthy palpebral conjunctiva, round
rey bodies can be seen at the surface, which probably represent
pithelial cell nuclei (Fig 1A; further images of normal conjunctiva
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Hu et al  In Vivo Confocal Microscopy in Trachomacan also be seen in Fig 2, available at http://aaojournal.org).
These are not always readily seen, and it is difficult to determine
how many layers there are with IVCM. Scattered among the
epithelial cells and extending beneath them are bright bodies (Fig
1B), which have been described as inflammatory cell nuclei. These
are heterogeneous in size and shape, with some being circular and
others multi-lobulated. These scattered presumed inflammatory
cells are present to a depth of approximately 20 m. Dendritiform
cells (DCs) are sometimes seen near the surface of the conjunctiva
(Fig 1C). These appear as bright structures with cell bodies and
multiple processes. In clinically normal conjunctiva, these pro-
cesses are relatively short and there is usually no interdigitation
with those of other DCs.
Round black spaces are often seen in the superficial conjunc-
tiva, previously described as “microcysts” (Fig 2F, available at
http://aaojournal.org). Sequential scanning shows these to be tu-
bular in shape. The spaces contain highly reflective material, often
in the form of discrete, round particles or cells. There is also often
a bright reflection around their edge, suggestive of encapsulation.
Approximately 20 to 30 m below the surface, a fine network of
small blood vessels is usually seen (Fig 1D). These are surrounded
by brightly reflective fibrous material that is probably supportive
Figure 1. Normal tarsal conjunctiva. Images are 400400 m with the ba
nuclei; note heterogeneity in size and shape (arrow). C, Dendritic cells (connective tissue. Beneath the small blood vessels, there is loose ronnective tissue within which few, if any, cells are seen (see
onjunctival Scarring section below). Deep blood vessels, which
re much broader than the more superficial network, can be seen at
ariable depths with blood flowing inside (Fig 2H, available at
ttp://aaojournal.org). Sometimes an oblique view is obtained (as
pposed to the usual en face), as a result of unequal apposition of
he PMMA cap on the conjunctival surface, which gives some
ppreciation of the various strata in the tissue (Fig 2I, available at
ttp://aaojournal.org).
If confocal microscopy is performed on the marginal portion of
he palpebral conjunctiva, next to the lid margin, then adenoid
tructures can be seen, which probably represent meibomian gland
ucts or acinar units (Fig 2J, available at http://aaojournal.org).
he IVCM appearance of palpebral conjunctiva in children and
oung adults is similar to that of older adults. One feature observed
n the conjunctiva of approximately 20% of children (both clini-
ally normal and inflamed) was fine blood vessels seen in cross-
ection (Fig 2K, available at http://aaojournal.org). Unlike the
ther small vessels mentioned above, which are parallel to the
onjunctival surface, these vessels are perpendicular. They ex-
ended from a very superficial level to around the level of the usual
ascular network at 20 m and were surrounded with highly
esenting 50 m. A, Superficial epithelial cell nuclei. B, Inflammatory cell
). D, Superficial blood vessels.r repreflective connective tissue.
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Ophthalmology Volume 118, Number 4, April 2011Active Trachoma in Children
All of the children with active trachoma examined by IVCM were
grade F2 or P2 on the World Health Organization grading system
(i.e., having a significant number of follicles or papillary inflam-
mation). Follicular structures occasionally were found (Fig 3A,
available at http://aaojournal.org), which were formed of discrete
collections of moderate to highly reflective round cell nuclei. They
began at approximately 10 m below the surface and were roughly
spherical with an estimated maximum diameter of approximately
0.5 to 1 mm.
Approximately half of the children with active disease had
black, “cystic” spaces or lacunae near the conjunctival surface,
which may reflect areas of tissue edema (Fig 3B, available at
http://aaojournal.org; corresponding image from an adult is shown
in Fig 4D). These lacunae were generally larger and more irregular
in outline than the microcystic spaces seen in normal conjunctiva,
and they did not have the surrounding bright edge, suggestive of
encapsulation. These spaces were largely acellular with no flow
seen, which suggests that they are not blood vessels. Approxi-
mately half of the children also had a network or honeycomb of
interconnecting bands (Fig 3C, available at http://aaojournal.org).
This network was seen near the surface and extended into the
Figure 4. Active disease in adults with conjunctival scarring. Images are
infiltrate. B, Follicular structure. C, Activated DCs. D, Cystic lacunae. Dtissue for a variable distance. Small vessels were often seen near h
750he surface in the central areas of this network, and it is likely that
his appearance represents tiny papillae. Dendritiform cells were
een more frequently in children with active disease and, when
resent, were more numerous and had longer dendritic processes
hat often interdigitated (Fig 3D, available at http://aaojournal.org).
rachomatous Inflammation in Adults with
onjunctival Scarring
linical inflammation is often seen in adults with trachomatous
carring. In adults with clinical inflammation and scarring, IVCM
ften reveals an increase in the inflammatory cell infiltrate that was
ore marked than in children with active disease (Fig 4A; further
mages of conjunctiva from adults with inflammation and scarring
an also be seen in Fig 5, available at http://aaojournal.org). This
ncreased cellularity is most prominent in the superficial conjunc-
iva, rarely extending beyond 20 m. Papilliform structures, com-
osed of discrete conjunctival elevations with central vessels were
een with IVCM (Fig 5B, available at http://aaojournal.org). Fol-
icular structures (0.5 mm) were also observed in some subjects
Fig 4B), although follicles were rarely seen clinically. Cystic
acunae and DCs were also seen in adults (Fig 4C, D). The
400m with the bar representing 50 m. A, Increased inflammatory cell
dendritiform cells.400oneycomb of interconnecting bands was rarely seen.
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Hu et al  In Vivo Confocal Microscopy in TrachomaFor the evaluation of markers of inflammatory activity, we
ropose the grading scheme shown in Table 1. There was some
ariation in the inflammatory cell count density between images
aken from different areas of the same conjunctival surface. For 30
ubjects, we measured the cell count in the full 10 volume scans
aken for each subject. From the variation in these estimates from
he same lid, we found that the average cell count score of 3
andom images provided sufficient precision.
onjunctival Scarring
he appearance of the subepithelial connective tissue (starting at
30 m from the surface) in individuals with clinically visible
rachomatous conjunctival scarring varied widely. At the mild end
f the spectrum, the appearance was similar to that seen in normal
ontrols: mostly moderately reflective, amorphous tissue with a
ew fine, wispy strands randomly arranged. With increasing sever-
ty of clinically visible scarring, increasingly marked changes were
ound in the deeper subepithelial connective tissue. In the more
evere cases, we observed broad bands of highly reflective con-
ective tissue that were often arranged in parallel, with a striated
texture.” We interpret this appearance as organized bands of scar
issue. By reviewing these images, we developed a 4-point grad-
ng system for the degree of subepithelial connective tissue
rganization/scarring: normal to grade 3. Definitions and charac-
eristic examples are provided in Figures 6 and 7 (available at
ttp://aaojournal.org).
An overall IVCM connective tissue organization/scarring grade
an be calculated with this grading system. Each volume scan is
iven a score of 0 (normal), 1 (grade 1), 2 (grade 2), or 3 (grade
). If the grade varies between the individual images of the volume
igure 6. Conjunctival connective tissue organization/scarring grading
ystem for IVCM. Images are 400400 m. A, Normal: homogenous,
morphous appearance with occasional fine, wispy strand. B, Grade 1:
eterogeneous appearance with poorly defined clumps or bands present.
, Grade 2: clearly defined bands of tissue that constitute 50% of the
rea of the scan. D, Grade 3: clearly defined bands or sheets of tissue that
onstitute50% of the area of the scan and in which striations are visible.
f different grades of scarring are seen within a particular volume scan,
hen the highest grade is recorded. The connective tissue that is graded
eeds to be separate from that associated with the vascular tissue; if this is
ot possible then the scan is considered ungradable. IVCM  in vivo
Table 1. Conjunctival Inflammation Grading System for In
Vivo Confocal Microscopy
Feature Grading Description
nflammatory
infiltrate
Mean inflammatory cell density of 3 randomly
selected volume scans*
Cs Present or absent: to be present, the mean number of
DCs per volume scan needs to be 1†
issue edema Present or absent: present if seen in any volume scan
apillae Present or absent: present if seen in any volume scan
C  dendritiform cells.
Cell density is measured with the RCM software, for which it is suggested
hat a minimum of 50 cells is counted per field. See text for explanation
f why 3 scans are selected. The individual scan with the largest density of
ells from within the volume scan is used to calculate the density.
The largest number of DCs in any individual scan in a particular volume
can is used.onfocal microscopy.
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Ophthalmology Volume 118, Number 4, April 2011scan, then the highest grade is used. The mean score for that
patient is then calculated by dividing the sum of the volume scan
scores by the number of volume scans read. At least 3 gradable
volume scans need to be available to generate a mean score. The
minimum score possible is therefore 0 and the maximum is 3 (if
each volume scan score was 0 or 3, respectively).
Interobserver agreement was assessed by calculating the intra-
class correlation coefficient on the mean scores of 50 patients.
These were graded independently by VH and MB, who were also
masked to the clinical appearance. The intraclass correlation co-
efficient showed a high agreement of 0.88, that is, 88% of the total
variance was due to between individual variation (rather than
between observer variation).
As described in the methodology, up to 10 sets of volume scans
were taken from each subject. We found that the scarring grade
generally showed little variation between the multiple images
taken from different areas of the same tarsal conjunctiva. Analysis
of the image grading of 50 randomly selected subjects with con-
junctival scarring showed that all the separate volume scans of
74% of individuals had a difference of 1 (i.e., all scores were
within 1 grade of each other). Only 1 individual had a range of 3.
Meibomian glands were not systematically imaged as part of
the study protocols. However, acinar units at the marginal epithe-
lium were seen in a few subjects with trachomatous scarring. In a
limited number of scans, the lumen of these acinar units was seen
to contain low reflectivity material, possibly scar tissue (Fig 8A,
available at http://aaojournal.org). The walls of the units were also
poorly defined, in contrast with those from normal subjects. In
subjects with more advanced scarring, concretions were also a
frequent finding (Fig 8B, available at http://aaojournal.org).
Discussion
The pathogenesis of trachoma has been studied from vari-
ous angles, but these have tended not to show what is
happening at a tissue or cellular level.19–22 A number of
studies have used histopathology and immunohistochemis-
try. However, these involve an invasive biopsy procedure
and analysis is restricted to a tiny amount of tissue.23 We
have carried out a large number of IVCM examinations in
both trachomatous and clinically non-scarred subjects to
gain insights into the pathophysiology of progressive con-
junctival scarring in trachoma. To the best of our knowl-
edge, this is the first time IVCM has been reported from
individuals with trachoma or from children.
Follicular and papillary inflammation are the key fea-
tures of active trachoma. Follicular structures can be seen
with IVCM in the subepithelial tissue, probably composed
of the nuclei of inflammatory cells and corresponding to
follicles seen clinically. Histologic analysis has shown these
to be composed mainly of B cells with some macrophages
and T cells.23,24 Follicles in adults may be seen on histology
without being a prominent clinical feature, and these folli-
cles seem to be morphologically distinct from those in
children in that they lack germinal centers.25
Papillae are composed of engorged blood vessels with an
edematous/inflamed overlying epithelium that varies in size.
Adults with inflammation commonly had papillae seen with
IVCM. These have been noted in the palpebral conjunctiva
of patients with atopic keratoconjunctivitis.10 These papillae
were not commonly seen among children with active dis-
ease. Children did, however, often have structures corre- s
752ponding to tiny, or micro, papillae: (1) a honeycomb ap-
earance of the tissue with small blood vessels within the
ells of the honeycomb and (2) small, superficial vessels
erpendicular to the conjunctival surface with prominent
urrounding connective tissue. The latter were seen in chil-
ren with and without clinically apparent inflammation. We
uggest that these vessels formed during papillary inflam-
ation and slowly recede once the inflammation has re-
olved. We would not, therefore, expect this appearance to
e found in a population of children from a non-trachoma
ndemic area.
Another morphologic change seen in active trachoma is
he appearance of what has been described as “inflammatory
acunae.”26 A feature of active trachoma is thickening of the
pper tarsal conjunctiva probably due to edema,27 and this
robably corresponds to the IVCM finding of these lacunar
paces. This edema has not been observed in histologic
tudies. However, the processing of histopathology speci-
ens may cause disruption with loss of the spaces.
Changes in cell populations were seen in both children
nd adults with clinical inflammation. The brightly reflec-
ive nuclei seen within and below the epithelium probably
elong to inflammatory cells, such as neutrophils or lym-
hocytes.7,10,11,28 This inflammatory infiltrate has been
ound to be elevated in patients with atopic keratoconjunc-
ivitis compared with controls.26 In addition, subconjuncti-
al injection of lipopolysaccharide in rabbit eyes resulted in
significant increase in the infiltrate.11 Histopathologic
nalysis shows a marked inflammatory infiltrate in trachoma
f mixed cell types,23,25,29 and IVCM shows that this in-
ammatory infiltrate is generally limited to the superficial
0 m.
Dendritiform cells have been found with ocular surface
VCM, and studies have been done on their density and
istribution in the cornea.5,30 We found DCs to be increased
n children and adults with inflammation and that they had
onger dendritic processes that frequently interdigitated. In
ddition to being the only antigen-presenting cells that are
ble to induce primary immune responses, dendritic cells
re also important in the regulation of the type of T-cell
esponse and the development of immunologic toler-
nce.31,32 The type of immune response (e.g., a type 1 vs
ype 2 T-helper response) seems to be important in tra-
homa in determining whether infection is resolved rapidly
r a chronic inflammatory reaction develops.20,33,34 The
tudy of dendritic cells in trachoma is also important be-
ause their role is likely to be important in the design of any
hlamydial vaccine.35 However, although IVCM studies
ave generally labeled DCs as being Langerhans or den-
ritic cells, immunohistochemistry is needed because other
ell types may also have a dendritic morphology.
We are aware of 2 previously published IVCM images of
onjunctival scarring. The first of these was from patients
ith atopic keratoconjunctivitis with an appearance similar
o that found in trachoma with organized bands of connec-
ive tissue.10 The second report shows an unusual honey-
omb type appearance that we have not observed else-
here.8 The subepithelial tissue of nonfunctioning blebs
hows dense connective tissue with few or no clear spaces,
imilar to that observed in scarred subjects. Histologic stud-
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Hu et al  In Vivo Confocal Microscopy in Trachomaies of trachomatous scarring have shown the conjunctival
stroma to be replaced with compact, largely avascular scar
tissue.36,37 The tissue organization that we observed with
IVCM probably shows collagen fibrils that, in keeping with
the histology, may be haphazardly arranged or, in more
advanced cases, parallel to each other.
In addition to studying subjects with trachoma, we also
examined the palpebral conjunctiva of a larger number of
healthy subjects than has previously been done. The appear-
ance of the tarsal conjunctiva in healthy children is largely
similar to that of adults. Images of epithelial cells of the
tarsal conjunctiva in an oblique view have been published,
which are similar to those we found.7 It has been reported,
using IVCM, that the palpebral conjunctival epithelium is
organized in 6 to 7 cell layers.28 However, this was also
based on an oblique view that may have overestimated the
number of layers, which was significantly more than we or
previous histologic studies found.38 Another published im-
age of the palpebral conjunctival epithelium probably shows
images from the marginal portion of the palpebral conjunc-
tiva,39 shown from one of our study subjects in Figure 9
(available at http://aaojournal.org).
The “microcystic” spaces that we found in normal pal-
pebral conjunctival epithelium have been observed by other
investigators.8,39 It is only speculative whether these spaces
are actually cystic because it is unknown whether they are
lined by epithelium. It is also unknown what these spaces
and the debris seen within them represent. It has been
suggested that they are occluded goblet cells,39 although
they seem too large for this and to extend too deep into the
tissue. They may represent mucous crypts, which are tubu-
lar structures consisting of clusters of goblet cells arranged
around a central lumen with an overall diameter of 50 m.38
Kessing40 states that there may be stagnation of mucin in
these crypts leading to the formation of cysts. Goblet cells
are not visible perhaps because they are of a similar reflec-
tivity to the surrounding tissue in the palpebral conjunctiva
and the HRT3/RCM is unable to differentiate them.
In vivo confocal microscopy offers a unique opportunity
of studying tissue morphology and cellular activity in nor-
mal and diseased states. It is not invasive or harmful and can
be used repeatedly. A high level of resolution is gained,
almost comparable to histologic analysis. Once proficiency
with the HRT3/RCM is achieved, images can be obtained
within a few minutes, and we have found the machine to be
robust and portable. There are, however, some limitations
with the technique. The RCM requires contact with the
tissue surface, which is not always well tolerated despite
topical anesthesia. It can be difficult to satisfactorily posi-
tion the everted upper lid, especially if the subject has
limited mobility. The PMMA cap is currently relatively
large and can impede good positioning on the conjunctival
surface. The combination of the large cap and very small
image area precludes identification of the exact location
being imaged. The exact same area cannot, therefore, be
imaged sequentially to observe temporal changes. In vivo
confocal microscopy in its current state cannot be used in
conjunction with tissue/cellular staining, an integral part of
histologic-immunohistochemical analysis that yields much
valuable information. In vivo confocal microscopy is aelatively new technique, and histologic confirmation of
hese appearances is needed. We are currently in the process
f conducting a case-control study of subjects with tracho-
atous trichiasis who are undergoing conjunctival biopsies
t the time of trichiasis surgery. This will enable a system-
tic comparison of IVCM and histologic findings.
In conclusion, this article presents descriptive IVCM
ndings gained from examining a large number of subjects
ith trachoma compared with healthy control subjects, in-
luding children. We also present grading systems for ana-
yzing conjunctival images. We are currently applying this
rading system to a large case-control study of trachoma-
ous scarring in which we are correlating confocal micros-
opy findings with clinical grading. We hope the descrip-
ions presented will be of help in the interpretation of
mages from patients with a range of conjunctival diseases
nd further our understanding of trachomatous inflamma-
ion, scarring, and blindness.
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